CVR 29513538Private limited company (ApS)Fysio- og ergoterapi (869500)Secondary industries: Udlejning af erhvervsejendomme (682040)EsbjergFounded 18 Apr 2006
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about EMCARE ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
51
CVR, Aug 2026
-7 (-12.1%) over 12 months
Gross profit
16.7M
DKK, annual report 2025
+4.1% on 2024
Result
+322.6K
DKK, annual report 2025
Equity
-1.9M
DKK, annual report 2025
SØREN MØLLER KRISTENSEN HOLDING ApSCVR 35893563, 100% of capital and votes
Operating company
Dandex estimate: 51 employees registered in 2026Søren Møller Kristensensince 27 Jan 2011
Owners of 5% or more. CVR registers shares in bands, not exact figures.
CVR 35893563100% of capital and votesnotified 23 Jan 2026since 2 Jul 2014
33.3% to under 50% of capital and votes4 Jan 2012 to 2 Jul 2014
33.3% to under 50% of capital and votes4 Jan 2012 to 2 Jul 2014
33.3% to under 50% of capital and votes4 Jan 2012 to 4 Jan 2012
CVR 3374716033.3% to under 50% of capital and votesnotified 1 Jan 202122 May 2011 to 1 Jan 2021
CVR 3589357133.3% to under 50% of capital and votesnotified 31 Dec 20252 Jul 2014 to 31 Dec 2025
CVR 4199589020% to under 25% of capital and votesnotified 23 Jan 20265 Jan 2021 to 31 Dec 2025
Ultimate controller
Holding in SØREN MØLLER KRISTENSEN HOLDING ApS, since 2 Jul 2014
Holding company
SØREN MØLLER KRISTENSEN HOLDING ApS
CVR 35893563Private limited company (ApS)
Holding in EMCARE ApS, since 2 Jul 2014
This company
EMCARE ApS
CVR 29513538
4 Danish companies, which own 1 more one level down.
SubsidiaryCVR 44401371100% of capital and votes
CVR 4495058825% to under 33.3% of capital and votes
Subsidiary or joint ventureCVR 4617393750% to under 66.7% of capital and votes
CVR 4538244333.3% to under 50% of capital and votes
CVR 3552936520% to under 25% of capital and votes
Danish companies held at 5% or more, from the CVR owner register (ejerregister), and their holdings one level down. Foreign holdings are not in CVR. Subsidiary (datterselskab): 50% or more of the votes, a Dandex estimate; in the 50% band a joint venture is not ruled out.
CVR 3953372333.3% to under 50% of capital and votes25 Apr 2018 to 27 Dec 2023
CVR 3488492710% to under 15% of capital and votes14 Dec 2012 to 2 Dec 2019
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Aug 2026, monthly: 51 employees, 26 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 2006 | 2007 | 2008 | 2009 | Q1 2010 | Q2 2010 | Q3 2010 | Q4 2010 | 2011 | 2012 | 2013 | 2014 | Jan 2015 | Feb 2015 | Mar 2015 | Apr 2015 | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 | Jan 2016 | Feb 2016 | Mar 2016 | Apr 2016 | May 2016 | Jun 2016 | Jul 2016 | Aug 2016 | Sep 2016 | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 6 | 9 | 13 | 16 | No count | No count | No count | No count | 18 | 22 | 26 | 23 | 32 | 29 | 37 | 42 | 43 | 42 | 40 | 41 | 40 | 40 | 34 | 36 | 34 | 37 | 46 | 49 | 49 | 49 | 46 | 46 | 48 | 48 | 47 | 37 | 41 | 40 | 45 | 42 | 52 | 45 | 44 | 48 | 47 | 45 | 48 | 37 | 36 | 37 | 43 | 49 | 53 | 60 | 56 | 56 | 56 | 54 | 51 | 49 | 52 | 56 | 59 | 64 | 69 | 66 | 64 | 62 | 64 | 67 | 73 | 69 | 71 | 73 | 73 | 50 | 57 | 71 | 72 | 75 | 75 | 75 | 80 | 77 | 65 | 64 | 64 | 65 | 69 | 80 | 72 | 74 | 76 | 80 | 81 | 81 | 80 | 80 | 83 | 116 | 122 | 122 | 113 | 116 | 116 | 115 | 114 | 106 | 103 | 93 | 92 | 88 | 88 | 84 | 82 | 85 | 85 | 86 | 87 | 82 | 59 | 59 | 57 | 58 | 58 | 57 | 55 | 57 | 55 | 56 | 57 | 59 | 57 | 58 | 58 | 58 | 60 | 60 | 60 | 58 | 56 | 55 | 56 | 52 | 53 | 54 | 53 | 55 | 54 | 54 | 51 | 51 |
| FTE | 1 | 4 | 7 | 8 | 8 | 11 | 12 | 10 | 8 | 11 | 13 | 14 | 23 | 22 | 23 | 26 | 27 | 27 | 27 | 27 | 25 | 26 | 21 | 21 | 21 | 23 | 23 | 27 | 27 | 27 | 28 | 30 | 29 | 29 | 27 | 25 | 27 | 26 | 28 | 26 | 32 | 28 | 30 | 34 | 32 | 32 | 27 | 24 | 22 | 26 | 26 | 33 | 32 | 32 | 34 | 36 | 34 | 34 | 31 | 29 | 33 | 35 | 35 | 40 | 41 | 39 | 40 | 40 | 40 | 41 | 42 | 44 | 41 | 46 | 42 | 35 | 25 | 42 | 44 | 47 | 44 | 46 | 45 | 48 | 43 | 42 | 39 | 44 | 43 | 42 | 42 | 47 | 45 | 47 | 46 | 46 | 45 | 46 | 42 | 63 | 62 | 60 | 60 | 58 | 58 | 56 | 53 | 53 | 50 | 50 | 48 | 51 | 46 | 45 | 44 | 42 | 44 | 43 | 44 | 42 | 33 | 33 | 34 | 31 | 31 | 32 | 29 | 29 | 28 | 27 | 28 | 35 | 29 | 33 | 32 | 34 | 32 | 32 | 31 | 29 | 28 | 27 | 29 | 26 | 26 | 27 | 25 | 28 | 28 | 26 | 24 | 26 |
| Series | Annual | Annual | Annual | Annual | Quarterly | Quarterly | Quarterly | Quarterly | Annual | Annual | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group. CVR changed its monthly method in Oct 2019: a step there need not be real.
Source: CVR, latest Aug 2026, published 21 Oct 2026.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2025, DKK: Gross profit 16.7M, Operating profit 972.3K, Result for the year 322.6K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2025, DKK: Total assets 11.5M, Equity -1.9M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 19,148 | 21,390 | 17,963 | 16,026 | 16,677 |
| Operating profit | +797 | -1,396 | +441 | -752 | +972 |
| Result for the year | +567 | -1,185 | +356 | -2,616 | +323 |
| Equity | 1,233 | 48 | 404 | -2,212 | -1,889 |
| Total assets | 8,440 | 11,844 | 13,586 | 10,702 | 11,461 |
| Employees (average) | 39 | 50 | 42 | 29 | 29 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | 14.4% | 12.8% | -20.8% | -10.8% | 19.1% |
| EBITDA | 1,542 | -524 | 1,108 | -41 | 1,626 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Employee growth (vækst i antal ansatte) | -9.3% | 16.3% | 0% | -31% | 0% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | 996note 1 | 1,987note 1 | Not reportednote 2 | 273note 1 | Not reportednote 2 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for EMCARE ApS:
Have Pro? Sign in.
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 1,750,000, cash price 14.00, implied value 5,250,000 | 14.00 | 1,750,000 | 5,250,000 | 375,000 | |
| DecreasePaid out to the owners, DKK 250,000 | None | None | None | 250,000 | |
| IncreaseCashPaid in 325,000, cash price 2.60, implied value 975,000 | 2.60 | 325,000 | 975,000 | 375,000 | |
| FoundingNot read from the announcement | None | None | None | 250,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Demerger (spaltning), as the receiving company (modtagende selskab)
Source: CVR, read 17 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 17 Nov 2026.
27 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Vedtægter ændret: 22.06.2026
Bestyrelse:
Fratrådte:
Søren Møller Kristensen, den 22.06.2026, Knud Ole Sinkjær-Knudsen, (formand), den 22.06.2026, Klaus Sørensen, den 22.06.2026.
Selskabet tegnes af direktøren.
Bestyrelse:
Fratrådte:
Corna Levin Munch, den 13.06.2025.
Bestyrelse:
Fratrådte:
Palle Kjær, (formand), den 21.06.2023, Knud Ole Sinkjær-Knudsen, den 21.06.2023.
Tiltrådte:
Knud Ole Sinkjær-Knudsen, (formand), den 21.06.2023.
Bestyrelse:
Fratrådte:
Michael Nikkelsen Solhøj, den 17.05.2021.
Tiltrådte:
Corna Levin Munch, den 17.05.2021.
Bestyrelse:
Fratrådte:
Mette Ibsen Scherfig, den 31.12.2020.
Bestyrelse:
Fratrådte:
Ove Dahl Jensen, (formand), den 18.05.2020, Anette Maagaard, den 18.05.2020.
Tiltrådte:
Palle Kjær, (formand), den 18.05.2020.
Ny adresse: Helgolandsgade 17B, 6700 Esbjerg
CVR-nummer:
29513538.
NAVN:
EMCARE ApS.
Adresse: Helgolandsgade 17, 6700 Esbjerg.
Kommune: Esbjerg.
Revision:
Tiltrådte:
CVR-NR. 26993695 DANSK REVISION ESBJERG REGISTRERETREVISIONSAKTIESELSKAB, Smedevej 33, 6710 Esbjerg V, den 13.05.2015.
CVR-nummer:
29513538.
NAVN:
EMCARE ApS.
Adresse: Helgolandsgade 17, 6700 Esbjerg.
Kommune: Esbjerg.
Revision:
Fratrådte:
MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 13.05.2015.
Revision:
Udtrådt af revisionen:
BDO Statsautoriseret Revisionsaktieselskab, den 14.11.2014.
Indtrådt i revisionen:
MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB, Hedemarken 23, Dal, 7200 Grindsted, den 14.11.2014.
Vedtægter ændret:
08.10.2014.
Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse i forening.
Vedtægter ændret:
25.04.2014.
Nye binavne:
EMCARE SUNDHED ApS, ESBJERG FYSIOTERAPI OG TRÆNINGSKLINIK ApS, IDRÆTSSKADEKLINIKKEN ApS, MOTORISK MED ApS.
Revision:
Udtrådt af revisionen:
PARTNER REVISION VEST, REGISTRERET REVISIONSAKTIESELSKAB, den 31.12.2013.
Indtrådt i revisionen:
BDO Statsautoriseret Revisionsaktieselskab, Torvet 2, 6870 Ølgod, den 31.12.2013.
Ny adresse:
Helgolandsgade 17, 6700 Esbjerg.
Vedtægter ændret:
01.04.2013.
Bestyrelse:
Fratrådt som formand, men forbliver i bestyrelsen: Knud Ole Sinkjær-Knudsen, den 01.04.2013.
Indtrådt i bestyrelsen:
Ove Dahl Jensen (formand), den 01.04.2013, Skoleleder Anette Maagaard, den 01.04.2013, Advokat Michael Nikkelsen Solhøj, den 01.04.2013.
Revision:
Indtrådt i revisionen:
PARTNER REVISION VEST, REGISTRERET REVISIONSAKTIESELSKAB, Torvet 2, 6870 Ølgod, den 08.06.2012.
Revision:
Udtrådt af revisionen:
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 08.06.2012.
Vedtægter ændret:
04.01.2012.
Bestyrelse:
Udtrådt af bestyrelsen:
Anita Ibsen, den 04.01.2012.
Indtrådt i bestyrelsen:
Mette Ibsen Scherfig, den 04.01.2012.
Revision:
Udtrådt af revisionen:
DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB, den 13.10.2011.
Indtrådt i revisionen:
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB, Frodesgade 125, 6700 Esbjerg, den 13.10.2011.
Vedtægter ændret:
27.01.2011.
Kapitalforhøjelse:
kr. 125.000,00 indbetalt kontant, kurs 1.400,00.
Kapitalen udgør herefter kr. 375.000,00.
Bestyrelse:
Indtrådt i bestyrelsen:
Fysioterapeut Knud Ole Sinkjær-Knudsen (formand), den 27.01.2011, Fysioterap Anita Ibsen, den 27.01.2011, Fysioterapeut Søren Møller Kristensen, den 27.01.2011.
Direktion:
Udtrådt af direktionen:
Knud Ole Sinkjær-Knudsen, den 27.01.2011.
Indtrådt i direktionen:
Fysioterapeut Søren Møller Kristensen, den 27.01.2011.
Selskabet tegnes af den samlede bestyrelse i forening.
Vedtægter ændret:
23.10.2009.
Kapitalnedsættelse besluttet 23.10.2009 er gennemført 25.01.2010.
Kapitalen udgør herefter kr. 250.000,00.
Binavn:
BLÅVANDSHUK FYSIOTERAPI ApS (EMCARE ApS).
Kapitalnedsættelse besluttet 23.10.2009 med udbetaling til anpartshavere kr. 125.000,00 til kurs 200,00.
Selskabets kreditorer opfordres til at anmelde deres krav til selskabet. Kreditorerne kan kræve betryggende sikkerhed for uforfaldne krav og betaling af forfaldne krav. Krav skal anmeldes senest tre måneder fra dags dato.
Ny adresse:
Rolfsgade 75, 6700 Esbjerg.
Ny kommune:
Esbjerg.
Revision:
Udtrådt af revisionen:
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSAKTIESELSKAB, den 18.12.2008.
Indtrådt i revisionen:
DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB, Frodesgade 125, postboks 200, 6700 Esbjerg, den 18.12.2008.
Ved kommunalreformen den 1. januar 2007 er hjemstedskommunen ændret.
Vedtægter ændret:
27.04.2006.
Nyt navn:
EMCARE ApS.
Binavn:
BLÅVANDSHUK FYSIOTERAPI ApS (EMCARE ApS).
Kapitalforhøjelse:
kr. 125.000,00 indbetalt kontant, kurs 260,00.
Kapitalen udgør herefter kr. 375.000,00.
Binavn:
BLÅVANDSHUK FYSIOTERAPI ApS (NY EMCARE ApS).
Selskabet er stiftet ved spaltning, den 18.04.2006 Selskabets aktiver og gæld er overdraget fra CVR-NR. 27771971 EMCARE ApS, der samtidig er opløst.
Seneste vedtægtsdato:
18.04.2006.
Kapital:
kr. 250.000,00.
Indbetalingsmåde:
spaltning kr. 250.000,00 til kurs 250,40.
Direktion:
Fysioterapeut Knud Ole Knudsen, (adm. dir), 6740 Bramming, den 18.04.2006.
Selskabet tegnes af selskabets direktører i forening.
Revision:
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSAKTIESELSKAB, Østergade 40, 6900 Skjern, den 18.04.2006.
Første regnskabsår:
01.01.2006 - 31.12.2006.
Regnskabsår:
01.01 - 31.12.
P-number 1014709149Rolfsgade 75, 6700 Esbjerg
P-number 1012202578Rolfsgade 75, 6700 Esbjerg
P-number 1017364185Norgesgade 44, 6700 Esbjerg
P-number 1017367567Hvidbjerg Strandvej 27, 6857 Blåvand
P-number 1018846825Helgolandsgade 17, 6700 Esbjerg
P-number 1017364193Strandvejen 2, 6840 Oksbøl
P-number 1028183182Muslingevej 30, 8250 Egå
P-number 1017364177Gl Vardevej 60, 6700 Esbjerg
P-number 1028183239Damhaven 5, 7100 Vejle
P-number 1024161982Dalgasvej 20, 6800 Varde